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Objectives
The use of “real-time” data to support individual patient man-
agement and outcome assessment requires the development of
risk assessment models. This could be delivered through a
learning health system by the building robust statistical analysis
tools onto the existing linked data held by NHS ScotlandâĂŹs
Infection Intelligence Platform (IIP) and developed within the
Scottish Healthcare Associated Infection Prevention Institute
(SHAIPI).
This project will create prediction models for the risk of ac-
quiring a healthcare associated infection (HAI), and particular
outcomes, at the point of GP consultation/ hospital admission
which could aid clinical decision making.
Approach
We demonstrate the capability using the HAI Clostridium dif-
ficile (CDI) from 2010-2013. Using linked national individual
level data on community prescribing, hospitalisations, infections
and death records we extracted all cases of CDI and by compar-
ing to matched population-based controls, examined the impact
of prior hospital admissions, care home residence, comorbidi-
ties, exposure to gastric acid suppressive drugs and antibiotic
exposure, defined as both cumulative (total defined daily dose
(DDD)) and temporal antimicrobial exposure in the previous 6
months, to the risk of CDI acquisition. Antimicrobial exposure
was considered for all drugs and the higher risk broad spectrum
antibiotics (4Cs). Associations are assessed using conditional
logistic regression. Using cross-validation we assess the ability
of the model to accurately predict CDI infection. Risk scores for
acquisition of CDI are estimated by combining these predictions
with age and gender population incidence.
Results
In the period 2010-2013 there were 1446 cases of CDI with
matched 7964 controls. A significant dose-response relationship
for exposure to any antimicrobial (1-7 DDDs OR=2.3 rising to
OR=4.4 for 29+ DDDs) and, with elevated risk, to the 4C group
(1-7 DDDs OR=3.8 rising to OR=17.9 for 29+ DDDs). Expo-
sure elevates CDI risk most in the month after prescription but
for 4C antimicrobials the elevated risk remains 6 months later
(4C OR=12.4 within 1 month, OR=2.6 4-6 months later). The
risk of CDI was also increased with more co-morbidities, previ-
ous hospitalisations, care home residency, increased number of
prescriptions, and gastric acid suppression.
Conclusion
Despite limitations to current application in practice,(paucity of
patient level in-hospital prescribing data and constraints of the
timeliness of the data), when fully developed this system will
enable risk classification to identify patients most at risk of HAI
and adverse outcomes to aid clinical decision making.
∗Corresponding Author:
Email Address: kim.kavanagh@strath.ac.uk (K. Kavanagh)
http://dx.doi.org/10.23889/ijpds.v1i1.297
August 2016 c© The Authors. Open Access under CC BY-NC-ND 4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/deed.en)
